-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Patients who have been infected with the new crown virus may still face different symptoms related to the new crown after recovery, even if the original new crown symptoms are not serious
Recently, an analysis of a large-scale study including as many as 150,000 people with new crown infection showed that new crown infection was associated with an increased risk of multiple mental health disorders in the following year, including depression, anxiety, drug or alcohol abuse, Sleep disturbances, cognitive decline,
▲The research results were published in the authoritative medical journal "British Medical Journal" (BMJ).
Using a large health care database managed by the U.
For the same population, the research team just recently published another analysis of the long-term sequelae of the new crown
In the newly published paper, the researchers focused on a comprehensive assessment of the mental health of people infected with the new crown
The researchers used statistical modeling to compare the mental health outcomes of the infected population with a control group of two other groups of uninfected people (concurrent and before the outbreak)
The results of the analysis showed that compared to uninfected people, patients with Covid-19 were 60% more likely to experience mental health problems or require related medication in a year overall, which is equivalent to an increase in the number of people requiring a mental health diagnosis or prescription per 1,000 people.
They were 35% more likely to suffer from anxiety disorders and nearly 40% more likely to suffer from depression or stress-related problems, mental health problems that affect behavior and mood
In addition, people who recovered from COVID-19, whether mild or severe, were 41 percent more likely to suffer from sleep disturbances and 80 percent more likely to experience neurocognitive decline in the following year.
People infected with Covid-19 were 34% more likely to have an opioid use disorder, 20% more likely to be involved in alcohol or non-opioid use disorder, and 46% more likely to have suicidal thoughts
The researchers noted that the risk of mental disorders was highest among people hospitalized with Covid-19, but the trend was evident even among infected people who were not hospitalized
Covid-19 infection is often compared to the flu, and in this analysis, the researchers also observed that Covid-19 patients were consistently at higher risk for mental health illness than seasonal flu, both mild and severe requiring hospitalization
▲ The phenomenon observed in this study also attracted the attention of the authoritative academic journal "Science"
In a news report published in the journal Science, Professor Cecilie Bay-Richter, a neuroimmunologist at Aarhus University in Denmark, pointed out that it is still unclear how the new crown infection damages people's mental health, and follow-up animal studies are needed.
References:
[1] Yan Xie et al.
[2] COVID-19 patients face higher risk of brain fog and depression, even 1 year after infection.
[3] COVID-19 survivors face increased mental health risks up to a year later.
Retrieved Feb.
17, 2022 from https://medicalxpress.
com/news/2022-02-mental-health-disorders-covid-infection.
html
[4] COVID-19 survivors face increased mental health risks up to a year later.
Retrieved Feb.
17, 2022 from https://medicine.
wustl.
edu/news/covid-19-survivors-face-increased-mental-health -risks-up-to-a-year-later/
[5] Yan Xie et al.
, (2022) Long-term cardiovascular outcomes of COVID-19.
Nature Medicine.
Doi: https://doi.
org/10.
1038/s41591-022-01689-3